Dr. Madleen Jawad Sobhe Abu Aser*, Dr. Tareq Khaled Aldirdasawi, Dr. Ezzedine Qanoua, Dr. Hamdio Al Turk


Pseudomembranous colitis is inflammation of the colon that is most often a manifestation of clostridium difficile infection. That predominantly affects the lower gastrointestinal tract. Its main risk factors are antibiotic use, advanced age, and hospitalization. pseudomembranous colitis, clostridium difficile, antibiotics, pseudomem-branous, fulminant colitis. If laboratory testing and endoscopic finding for clostridium difficile infection are negative, then other less common etiologies should be sought to identify the correct diagnosis. Ischemic colitis, inflammatory bowel disease, medications, chemicals, vasculitis, and multiple infectious pathogens are responsible for non-clostridium difficile pseudomembranous colitis. Exposure history, chronic medical problems, and a current medication list will aid in narrowing the differential diagnosis. Histology varies significantly with underlying etiology and can establish the diagnosis. Treatment is specific to the underlying etiology. The purpose of this research article increase awareness of clinicians and other healthcare professionals about various etiologies of pseudomembranous colitis along with its histological finding and treatment. Our case was admitted from ER a Ten-year-old male patient with chief complaints of cramping left lower abdominal pain, abdominal distension, and loose stools with the passage of blood and pus per rectum, associated with high-grade fever for 10 days.

Keywords: Myoinositol, metformin, polycystic ovarian disease.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    AUGUST 2020 Issue has been successfully launched on 1 August 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction